e l f Beauty Inc vs Revolution Medicines Inc. Common Stock — how do they compare? e l f Beauty Inc trades at $109.15 (market cap $6.25B), while Revolution Medicines Inc. Common Stock trades at $191 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.5× e l f Beauty Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, e l f Beauty Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold e l f Beauty Inc for 25 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ELF | RVMD | |
|---|---|---|
Market Cap | $6.25B | $40.32B |
Volume | 1,099,552 | 4,855,734 |
Sector | Consumer Staples | Health |
52-Week High | $144.97 | $221.15 |
52-Week Low | $49.57 | $47.50 |
Typical Hold Time | 25 Days | 0 Days |
Enterprise Value | $6.84B | $37.02B |
Signals from Pluang's Aura AI — not financial advice
ELF Beauty trades at $107.95, up 2.78% with bullish technical signals and strong earnings beats. The stock shows robust revenue growth reaching $1.31B in 2025, though net margins compressed to 3.38% in 2026. Recent expansion includes rhode brand launches in Europe via Sephora and innovative marketing through original music albums. Analyst sentiment leans positive with 48% buy ratings despite a consensus price target of $95.91 below current levels.
Outlook remains growth-focused with international expansion driving opportunities, but premium valuation (P/E 108) and margin pressure pose risks. Institutional accumulation and technical strength support near-term upside, though investors should monitor execution on global growth initiatives against high expectations.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →